Disclaimer
We’re actively expanding Guideline Genius to cover the full UKMLA content map. You may notice some conditions not uploaded yet, or articles that only include diagnosis and management for now. For updates, follow us on Instagram @guidelinegenius.
We openly welcome any feedback or suggestions through the anonymous feedback box at the bottom of every article and we’ll do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

Total Live Articles: 326

Gonorrhoea

NICE CKS Gonorrhoea. Last revised Mar 2024.

BASHH Gonorrhoea 2025: Updated Guideline. Last updated Apr 2025.

Guidelines

Investigation and Diagnosis

Test of choice: NAAT

Sample collection methods:

  • Male 1st line: first pass urine (alternative: urethral swab)
  • Female 1st line: vulvovaginal swab (alternative: endocervical swab)

If MSM → also take rectal and pharyngeal samples

Other tests:

Test Description
Culture Should be obtained simultaneously with NAAT and BEFORE starting treatment

For drug susceptibility testing

Urethral swab For quick diagnosis in the presence of penile urethral discharge

Interpretation:

  • Polymorphonuclear leukocytes + gram -ve diplococci → gonococcal urethritis
  • Polymorphonuclear leukocytes alone → non-gonococcal urethritis (NGU)

 

Management

Refer ALL patients to GUM clinic / local specialist for management.

General Advice

Abstain from all sexual activity until 7 days after they and their partner(s) have completed treatment

Pharmacological Management

Take swabs for culture BEFORE starting treatment, and initiate empirical treatment immediately without awaiting susceptibility result:

  • 1st line: ceftriaxone 1g IM single dose
  • 2nd line:
    • Needle-sparing option (e.g. if needle phobia) → cefixime 400mg PO (2 doses 6-12 hours apart) + azithromycin 2g PO
      • BASHH recommends only using this regimen if antimicrobial susceptibility results are available
    • Penicillin-sparing option → gentamicin 200mg IM + azithromycin 2g PO

Partner Notification and Sexual Contacts Management

Partner Notification

  • If symptomatic men → notify all partners within the past 2 weeks (or most recent partner if more than 2 weeks ago)
  • If all other patients (i.e. asymptomatic men and women) → notify all partners within the past 12 weeks (3 months)

The partner notification period for gonorrhoea is 1/2 that of chlamydia

  • In chlamydia
    • Symptomatic men → 4 week lookback (vs 2 weeks)
    • All other patients (i.e., asymptomatic men and women) → 6 month lookback (vs 3 months)

Sexual Contacts Management

All sexual contacts should be tested:

  • Empirical treatment is NOT needed routinely for all sexual contacts:
  • Principle: only offer empirical treatment to those who test +ve for gonorrhoea
  • If present within 2 weeks of exposure → repeat testing after 2 weeks

Follow Up

Offer test of cure using NAAT to all patients at least 2 weeks after treatment completion

  • BASHH recommends if treated with ceftriaxone + susceptible to ceftriaxone, there is no need for test of cure

At follow-up also:

  • If symptoms resolved or not
  • Adherence
  • Any adverse reactions
  • Confirm partner notification has been carried out
  • Ask about recent sexual history
  • Reinforce advice on safe sexual practice

 

Note the window period of gonorrhoea testing is 2 weeks, meaning false -ve is possible if tested within this period. Therefore, the test of cure should be performed ≥2 weeks after completion of treatment.

References

Original Guideline


Share Your Feedback Below

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD